Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-3153-2026

Haylard BASIC BIOPSY TRAY; Model/Item Number (Kit): PM415; Recall

Haylard BASIC BIOPSY TRAY; Model/Item Number (Kit): PM415;

FDA recall Class I

Ongoing

FDA lists this Class I recall for Haylard BASIC BIOPSY TRAY; Model/Item Number (Kit): PM415;. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-3153-2026
Recall classification
Class I
Enforcement status
Ongoing
Initiation date
Aug 10, 2026
FDA report date
Sep 23, 2026
Quantity in commerce
240 kits
Distribution
See key details
FDA cause
Nonconforming Material/Component

What is being recalled?

Haylard BASIC BIOPSY TRAY; Model/Item Number (Kit): PM415;

Affected model & UDI checker

Search the exact identifiers published for Z-3153-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedHaylard BASIC BIOPSY TRAY; Model/Item Number (Kit): PM415;Check source notice10809160322154
FDA code information

Model/Item Number (Kit): PM415; UDI-DI: 10809160322154; Kit Lots: 1652485, 1656642, 1667835, 1676219, 1682251, 1691940; Recalled Sodium Chloride Ampule Lot: AB5002, AB4003;

View the original FDA recall notice

Why was this product recalled?

Potential for product quality and sterility issues regarding kits containing Sodium Chloride ampules subject to recall by Spectra Medical.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did AVID Medical, Inc. take?

On August 10, 2026 URGENT: MEDICAL DEVICE RECALL letters were sent to customers. Actions to be taken: 1. Identify, Segregate, and Quarantine all impacted kits listed. 2. Add warning labels to affected kits to ensure all users are aware of the actions to take prior to use. A labeling template is enclosed for printing labels which can be affixed on all affected kits and cases in inventory. This label should be applied in a prominently visible location to end-users. The location chosen should not cover any other critical product information found on existing product labeling. If pre-printed labels are needed, please contact your sales representative. 3. REMOVE AND DISCARD the Sodium Chloride, 0.9%, USP 10 mL Flush ampules prior to use. 4. Customers (end-users): If you have received product from a distributor, please contact the distributor or your sales representative with any questions you may have. 5. Distributors: If any of the affected kits identified above were further distributed, please ensure all end-users are appropriately notified and maintain records of effectiveness. 6. Complete the attached Recall Response Form and return.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology